Skip to main content

Disposition of Mivacurium Isomers in Patients Undergoing Hypothermic Cardiopulmonary Bypass

  • Conference paper
Muscle Relaxants

Abstract

The muscle relaxant mivacurium (MIV), is made up of 3 isomers: trans-trans (tt; 55%), cis-trans (ct; 36%), and cis-cis (cc; 6%). Plasma cholinesterase (ChE) converts these compounds into 2 alcohol and 2 acid isomers. Hypothermic cardiopulmonary bypass (CPB) may be expected to impair these metabolic pathways by both reducing ChE activity and a direct effect of hypothermia. The present study was designed to analyse the disposition of the MIV isomers before, during and after CPB in the clinical setting.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Japan

About this paper

Cite this paper

Abel, M., Diefenbach, C., Aydincioglu, G., Theisohn, M., Buzello, W. (1995). Disposition of Mivacurium Isomers in Patients Undergoing Hypothermic Cardiopulmonary Bypass. In: Fukushima, K., Ochiai, R. (eds) Muscle Relaxants. Springer, Tokyo. https://doi.org/10.1007/978-4-431-66896-1_86

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-66896-1_86

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-66898-5

  • Online ISBN: 978-4-431-66896-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics